Jia-ying Wang

Nanjing, 210000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Vincamine as a GPR40 agonist shows potential in treating female Alzheimer's disease.

Vincamine as a GPR40 agonist shows potential in treating female Alzheimer's disease.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 31, 2025

PPM1A dysfunction aggravates DPN pathology through NF-κB/NLRP3/p-tau axis involving Schwann cell/DRG neuron crosstalk.

PPM1A dysfunction aggravates DPN pathology through NF-κB/NLRP3/p-tau axis involving Schwann cell/DRG neuron crosstalk.

Journal: Journal of translational medicine

Published: October 10, 2025

Ginsenoside Rb1 attenuates diabetic peripheral neuropathy pathology by functioning as a potent activator of isocitrate dehydrogenase 1.

Ginsenoside Rb1 attenuates diabetic peripheral neuropathy pathology by functioning as a potent activator of isocitrate dehydrogenase 1.

Journal: Journal of advanced research

Published: September 01, 2025

Selective inhibition of monoamine oxidase B represents a therapeutic strategy for diabetic peripheral neuropathy.

Selective inhibition of monoamine oxidase B represents a therapeutic strategy for diabetic peripheral neuropathy.

Journal: Acta pharmacologica Sinica

Published: August 13, 2025

Desloratadine as the selective 5HT2AR antagonist suppresses neutrophil extracellular traps formation to ameliorate diabetic peripheral neuropathy pathology.

Desloratadine as the selective 5HT2AR antagonist suppresses neutrophil extracellular traps formation to ameliorate diabetic peripheral neuropathy pathology.

Journal: Journal of neuroinflammation

Published: April 08, 2025

Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway.

Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway.

Journal: Acta pharmacologica Sinica

Published: October 28, 2024

Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.

Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.

Journal: Acta pharmacologica Sinica

Published: December 20, 2023

Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes.

Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes.

Journal: Acta pharmacologica Sinica

Published: July 21, 2023

Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice.

Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice.

Journal: Acta pharmacologica Sinica

Published: December 11, 2022

Khellin as a selective monoamine oxidase B inhibitor ameliorated paclitaxel-induced peripheral neuropathy in mice.

Khellin as a selective monoamine oxidase B inhibitor ameliorated paclitaxel-induced peripheral neuropathy in mice.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 18, 2022

Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.

Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 14, 2022

Central-to-Folding Chirality Control: Asymmetric Synthesis of Multilayer 3D Targets With Electron-Deficient Bridges.

Central-to-Folding Chirality Control: Asymmetric Synthesis of Multilayer 3D Targets With Electron-Deficient Bridges.

Journal: Frontiers in chemistry

Published: January 22, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026